Glomerular filtration rate changes in normoalbuminuric and microalbuminuric Type 2 diabetic patients and normal individuals A 10-year follow-up.

AIM To analyze the changes in the glomerular filtration rate (GFR) in a cohort of normoalbuminuric Type 2 diabetic (DM 2) patients and nondiabetic individuals. METHODS Sixty-five normoalbuminuric DM 2 patients [urinary albumin excretion rate (UAER) <20 microg/min] and 44 nondiabetic individuals recruited at baseline were followed for a mean period of 10 +/- 1 years. In addition to conventional clinical and metabolic variables, GFR ((51)Cr-EDTA technique) and UAER (immunoturbidimetric method) measurements were performed at baseline and at follow-up. We also evaluated the presence of diabetic retinopathy, hypertension, and cardiovascular disease. Multiple linear regression was performed to assess variables independently associated with GFR evolution in patients with Type 2 diabetes. RESULTS Fifty DM 2 patients and 32 nondiabetic individuals were included in the follow-up evaluation. Fourteen out of the 50 patients with Type 2 diabetes developed microalbuminuria. They presented a faster GFR decline (-0.39+/-0.24 ml/min/month; ANOVA, P=.0013) than did persistently normoalbuminuric (-0.16+/-0.16 ml/min/month) and nondiabetic individuals (-0.13+/-0.14 ml/min/month). Multiple linear regression analysis disclosed baseline fasting plasma glucose (FPG) along with the development of microalbuminuria as factors significantly related to a higher GFR decline. CONCLUSIONS Persistently normoalbuminuric patients and normal individuals presented a similar degree of GFR reduction related to the aging process. The slope was significantly enhanced in patients who developed microalbuminuria and was influenced by worse baseline glucose control.

[1]  T. Barratt,et al.  Estimation of Glomerular Filtration Rate from Plasma Clearance of 51-Chromium Edetic Acid , 1972, Archives of disease in childhood.

[2]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  J. Gross,et al.  Evolution of Glomerular Filtration Rate in Proteinuric NIDDM Patients , 1991, Diabetes Care.

[4]  C. Baylis,et al.  The aging glomerulus. , 1996, Seminars in nephrology.

[5]  J. Gross,et al.  The Receiver Operating Characteristics Curve in the Evaluation of a Random Urine Specimen as a Screening Test for Diabetic Nephropathy , 1997, Diabetes Care.

[6]  J. Gross,et al.  Accuracy of conversion formulae for estimation of glycohaemoglobin. , 1998, Scandinavian journal of clinical and laboratory investigation.

[7]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[8]  J. Gross,et al.  Five-Year Prospective Study of Glomerular Filtration Rate and Albumin Excretion Rate in Normofiltering and Hyperfiltering Normoalbuminuric NIDDM Patients , 1996, Diabetes Care.

[9]  Mark E Molitch,et al.  Nephropathy in diabetes. , 2004, Diabetes care.

[10]  J. Gross,et al.  Risk factors for microalbuminuria and macroalbuminuria in type 2 diabetic patients: a 9-year follow-up study. , 2002, Diabetes care.

[11]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[12]  J. Gross,et al.  Effect of age and sex on glomerular filtration rate measured by 51Cr-EDTA. , 1992, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[13]  H. Parving,et al.  The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy , 1993, Diabetologia.

[14]  A. H. Norris,et al.  The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. , 1976, Journal of gerontology.

[15]  G. Pacini,et al.  Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. , 2000, Diabetes.

[16]  S. Nielsen,et al.  Systolic Blood Pressure Relates to the Rate of Decline of Glomerular Filtration Rate in Type II Diabetes , 1993, Diabetes Care.

[17]  L. Groop,et al.  Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. , 1998, Diabetes care.

[18]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[19]  G. Beck,et al.  Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. , 1996, The New England journal of medicine.

[20]  D. Fliser,et al.  Renal haemodynamics in the elderly. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  O. Pedersen,et al.  Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  M. Mauer,et al.  Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. , 2003, Diabetes.

[23]  J. Gross,et al.  Glomerular Hyperfiltration in NIDDM Patients Without Overt Proteinuria , 1993, Diabetes Care.